FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Caswell Bruce
   2. Issuer Name and Ticker or Trading Symbol
MAXIMUS INC [MMS] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
President - Health Svcs
(Last)
(First)
(Middle)
11419 SUNSET HILLS ROAD		 3. Date of Earliest Transaction (Month/Day/Year)
01/18/2011
(Street)

RESTON, VA 20190-5207		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock (1) 01/18/2011   M   6,600 A $ 27.94 17,003.33 D  
Common Stock (1) 01/18/2011   S   6,500 D $ 65.70 (3) (4) (5) 10,503.33 D  
Common Stock (1) 01/18/2011   S   100 D $ 66.635 10,403.33 D  
Common Stock (2) 01/18/2011   S   3,513 D $ 62.41 6,890.33 D  
Common Stock (2) 01/18/2011   S   100 D $ 62.44 6,790.33 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $ 27.94 01/18/2011   M     6,600   (6)   (6) Common Stock 6,600 $ 0 43,400 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Caswell Bruce
11419 SUNSET HILLS ROAD
RESTON, VA 20190-5207		       President - Health Svcs

Signatures

 David R. Francis: As Attorney-In-Fact for: Bruce Caswell   01/20/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2010.
(2) These grants had previously been reported on Table II.
(3) Weighted average sale price for prices ranging from $65.52 to $66.46. 100 shares were sold at $65.52 per share; 23 shares were sold at $65.53 per share; 298 shares were sold at $65.56 per share; 200 shares were sold at $65.575 per share; 199 shares were sold at $65.58 per share; 197 shares were sold at $65.59 per share; 653 shares were sold at $65.60 per share; 44 shares were sold at $65.601 per share; 305 shares were sold at $65.61 per share; 101 shares were sold at $65.62 per share; 1 shares were sold at $65.625 per share; 100 shares were sold at $65.629 per share; 375 shares were sold at $65.63 per share; 100 shares were sold at $65.631 per share; 203 shares were sold at $65.64 per share; 100 shares were sold at $65.644 per share; 1 shares were sold at $65645 per share; 200 shares were sold at $65.65 per share; 400 shares were sold at $65.66 per share; (continued in following footnote)
(4) (continued from previous footnote) 285 shares were sold at $65.67 per share; 15 shares were sold at $65.675 per share; 200 shares were sold at $65.68 per share; 200 shares were sold at $65.69 per share; 300 shares were sold at $65.70 per share; 100 shares were sold at $65.705 per share; 100 shares were sold at $65.71 per share; 300 shares were sold at $65.72 per share; 100 shares were sold at $65.73 per share; 100 shares were sold at $65.74 per share; 100 shares were sold at $65.75 per share; 96 shares were sold at $65.76 per share; 100 shares were sold at $65.77 per share; 100 shares were sold at $65.78 per share; 4 shares were sold at $65.785 per share; 100 shares were sold at $65.80 per share; 100 shares were sold at $65.81 per share; 100 shares were sold at $65.82 per share; 100 shares were sold at $65.95 per share; 100 shares were sold at $65.991 per share; (continued in following footnote)
(5) (continued from previous footnote) 100 shares were sold at $66.36 per share; 100 shares were sold at $66.376 per share; 92 shares were sold at $66.45 per share; 8 shares were sold at $66.46 per share.
(6) Effective 10/18/2004 - Non Qualified Stock Options to acquire 50,000 shares of common stock were issued with the following vesting schedules Shares Vest Date 12,500 10/18/2005 12,500 10/18/2006 12,500 10/18/2007 12,500 10/18/2008 These options expire on 10/18/2014

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.